Leading the future of patient monitoring
Senzime is a pioneering medical device company specializing in precision-based patient monitoring systems.
Our mission is to safeguard every patient’s journey, from anesthesia to recovery.
Setting a new standard in intelligent, quantitative train-of-four (TOF) monitoring, through these unique features:
- TetraGraph® Level-of-Block Gauge™ enables confident decisions through a visual representation of neuromuscular block levels
- 6th generation algorithm provides cutting-edge precision in quantitative neuromuscular monitoring with 4x higher resolution
- TetraGraph® Adaptive Intelligence™ automates your workflow from induction to recovery with its series of specialized algorithms
Note: Orders will begin shipping in the United States in Q4. The device will be available in selected markets in Europe starting in 2025, with expansion into other regions contingent upon obtaining the necessary regulatory clearances and market readiness.
Supporting you from start to finish
We provide more than cutting-edge technology. Our commitment extends to helping you excel with resources and support tailored to your needs.
Learn about the latest clinical guidelines, get started with quantitative TOF monitoring, and access valuable insights to improve patient outcomes.
An industry shift through a unique sustainable approach
Senzime stands at the forefront of the healthcare industry with a distinct sustainable approach. Our core strategy is rooted deeply in sustainability, ingrained in every facet of our operations.
Our goal is clear: to be the industry leader in sustainable monitoring solutions and the preferred partner for healthcare systems seeking long-term sustainable commitments.